Doctors caution ‘Mounjaro brides’ against risky shortcuts as pre-wedding weight-loss injections surge in India

In India’s high-pressure wedding season, a new trend is taking shape as weight-loss drugs like Mounjaro and Wegovy gain popularity as quick pre-wedding transformation tools.

Originally developed to treat obesity and Type 2 Diabetes, these GLP-1 receptor agonists are now being promoted by some clinics and online platforms as fast-track solutions for brides seeking rapid weight loss before their big day. From curated “bridal packages” in New Delhi to targeted digital ads, the trend is reshaping how many approach wedding preparations.

For some users, the appeal lies in convenience and results. Individuals have reported significant weight loss in a short span, boosting confidence ahead of ceremonies. Others cite social pressures, including rejection in arranged marriage settings, as a driving factor behind turning to these medications.

However, medical experts are raising concerns over the growing “cosmetic” use of these drugs. Doctors stress that such treatments are meant for carefully selected patients under strict supervision—not as aesthetic shortcuts. Misuse, particularly through non-medical channels, can lead to side effects such as nausea, vomiting, and in rare cases, Pancreatitis.

Beyond immediate risks, specialists warn of longer-term issues. Discontinuing the drugs soon after weddings may result in rapid weight regain and metabolic instability, undermining overall health.

As India’s weight-loss market expands and access to such drugs increases, regulators and pharmaceutical companies are urging caution. Manufacturers including Eli Lilly and Novo Nordisk emphasise that these medications should only be used under professional medical guidance.

Experts underline a clear message: sustainable weight management should focus on long-term health, not short-term appearance.